Why the study?
The effectiveness of early PRRSV vaccination in suckling pigs remains debated due to potential interference from maternally derived antibodies and the immature immune system.
Does intranasal or intramuscular administration of PRRSV-2 MLV vaccine improve protective efficacy and immune responses against HP-PRRSV in 3-day-old piglets?
Does intranasal or intramuscular administration of PRRSV-2 MLV vaccine improve protective efficacy and immune responses against HP-PRRSV in 3-day-old piglets?
Early vaccination of 3-day-old piglets with PRRSV-2 MLV effectively reduces clinical signs of HP-PRRSV infection, with intranasal administration inducing higher specific T lymphocyte responses.
Answers are grounded in this paper and cite their sources.
Early MLV vaccination may aid suckling piglets; leaves open MDA interference and optimal route questions.
Early porcine reproductive and respiratory syndrome virus (PRRSV) infections in suckling pigs are commonly observed, emphasizing the need for early vaccination strategies. However, the effectiveness of early vaccination in suckling pigs remains debated due to potential interference from maternally derived antibodies (MDA) and the immature immune system of piglets. This study evaluated and compared protective efficacy and immune responses of intranasal (IN) and intramuscular (IM) administration of a commercial PRRSV-2 modified live virus (MLV) vaccine in 3-day-old piglets against a Thai highly pathogenic (HP)-PRRSV strain. Piglets from PRRSV-seropositive sows were randomly allocated to four groups: unvaccinated, unchallenged control (A-NEG); unvaccinated, HP-PRRSV-challenged control (B-POS); intramuscular vaccination with PRRSV-2 MLV (C-IM); intranasal vaccination with PRRSV-2 MLV (D-IN). At five weeks of age, piglets in the B-POS, C-IM, and D-IN groups were challenged with HP-PRRSV. Following challenge with HP-PRRSV, both C-IM and D-IN groups demonstrated significant reductions in fever and improved growth performance compared to the B-POS group. Notably, the C-IM group exhibited lower viral loads in the tracheobronchial lymph nodes (TBLN), while the D-IN group showed significantly reduced viral loads in the tonsils. As expected, neutralizing antibody against HP-PRRSV was low across all groups. Interestingly, the D-IN group exhibited enhanced systemic T lymphocyte responses, characterized by increased numbers of PRRSV-specific IFN-γ + -producing CD4 + and CD8 + T lymphocytes following viral challenge. Early vaccination of piglets with PRRSV-2 MLV effectively reduced clinical signs and improved growth performance during HP-PRRSV infection, regardless of the administration route. Notably, intranasal vaccination induced higher PRRSV-specific T lymphocytes responses, highlighting its potential as an alternative strategy for early vaccination in piglets. These findings underscore the importance of optimizing vaccination protocols to improve PRRSV control measures in swine farms, particularly against early PRRSV infections.
No takes yet. Share an insight, caveat, or question.
Prapattanakullawong et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: